XERIS PHARMACEUTICALS

xeris-pharmaceuticals-logo

Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The companyโ€™s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using syringes, auto-injectors, multi-dose pens, and infusion pumps. Xeris๏ฟฝ... ๏ฟฝ platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol and XeriJect offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.

#SimilarOrganizations #People #Financial #Website #More

XERIS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Diabetes Health Care Pharmaceutical Therapeutics

Founded:
2005-01-01

Address:
Chicago, Illinois, United States

Country:
United States

Website Url:
http://www.xerispharma.com

Total Employee:
101+

Status:
Active

Contact:
844-445-5704

Email Addresses:
[email protected]

Total Funding:
289.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Tag Manager Amazon IPv6 COVID-19 ASP.NET Amazon Virginia Region


Similar Organizations

9-meters-biopharma-logo

9 Meters Biopharma

9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

auris-medical-logo

Auris Medical

Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

bellicum-pharmaceuticals-logo

Bellicum Pharmaceuticals

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

cure-pharmaceutical-logo

Cure Pharmaceutical

Cure Pharmaceutical is a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies.

evecxia-therapeutics-logo

Evecxia Therapeutics

Evecxia Therapeutics is a pharmaceutical company that is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan.

exscientia-logo

Exscientia

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

gi-windows-logo

G.I. Windows

G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.

interius-biotherapeutics-logo

Interius BioTherapeutics

Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.

medigene-logo

MediGene

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

newbridge-pharmaceuticals-logo

NewBridge Pharmaceuticals

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

noema-pharma-logo

Noema Pharma

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

reneo-pharmaceuticals-logo

Reneo Pharmaceuticals

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

seagen-logo

Seagen

Seagen is dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCโ„ข platform.

vigeo-therapeutics-logo

Vigeo Therapeutics

Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.


Current Advisors List

marla-persky_image

Marla Persky Board Member @ Xeris Pharmaceuticals
Board_member
2018-04-01

john-kinzell_image

John Kinzell Advisor @ Xeris Pharmaceuticals
Advisor

dawn-halkuff_image

Dawn Halkuff Board Member @ Xeris Pharmaceuticals
Board_member
2018-05-01

bj-bormann_image

BJ Bormann Board Member @ Xeris Pharmaceuticals
Board_member

jeff-sherman_image

Jeff Sherman Board Member @ Xeris Pharmaceuticals
Board_member

paul-r-edick_image

Paul R Edick Board Chairman @ Xeris Pharmaceuticals
Board_member
2017-01-01

john-schmid_image

John Schmid Board Member @ Xeris Pharmaceuticals
Board_member
2017-09-01

Current Employees Featured

paul-r-edick_image

Paul R Edick
Paul R Edick Chairman & CEO @ Xeris Pharmaceuticals
Chairman & CEO
2017-01-01

kevin-mcculloch_image

Kevin McCulloch
Kevin McCulloch SVP, Global Operations & Business Development @ Xeris Pharmaceuticals
SVP, Global Operations & Business Development
2018-10-01

john-shannon_image

John Shannon
John Shannon Chief Operating Officer @ Xeris Pharmaceuticals
Chief Operating Officer
2017-03-01

christina-kline_image

Christina Kline
Christina Kline Vice President, Marketing @ Xeris Pharmaceuticals
Vice President, Marketing
2021-06-01

steven-prestrelski_image

Steven Prestrelski
Steven Prestrelski Chief Scientific Officer @ Xeris Pharmaceuticals
Chief Scientific Officer
2011-01-01

kenneth-johnson_image

Kenneth Johnson
Kenneth Johnson Senior Vice President @ Xeris Pharmaceuticals
Senior Vice President

beth-hecht_image

Beth Hecht
Beth Hecht Senior Vice President, General Counsel & Corporate Secretary @ Xeris Pharmaceuticals
Senior Vice President, General Counsel & Corporate Secretary
2018-01-01

allison-wey_image

Allison Wey
Allison Wey Senior Vice President of Investor Relations and Corporate Communications @ Xeris Pharmaceuticals
Senior Vice President of Investor Relations and Corporate Communications

Founder


john-kinzell_image

John Kinzell

Stock Details


Company's stock symbol is NASDAQ:XERS

Acquisitions List

Date Company Article Price
2021-05-24 Strongbridge Biopharma Strongbridge Biopharma acquired by Xeris Pharmaceuticals 267 M USD

Investors List

armistice-capital_image

Armistice Capital

Armistice Capital investment in Post-IPO Equity - Xeris Pharmaceuticals

deerfield_image

Deerfield

Deerfield investment in Post-IPO Equity - Xeris Pharmaceuticals

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Xeris Pharmaceuticals

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Xeris Pharmaceuticals

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Xeris Pharmaceuticals

merieux-equity-partners_image

Merieux Developpement

Merieux Developpement investment in Series C - Xeris Pharmaceuticals

wild-basin-investments_image

Wild Basin Investments

Wild Basin Investments investment in Series C - Xeris Pharmaceuticals

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Xeris Pharmaceuticals

palmetto-partners_image

Palmetto Partners

Palmetto Partners investment in Series C - Xeris Pharmaceuticals

asahi-kasei_image

Asahi Kasei

Asahi Kasei investment in Series C - Xeris Pharmaceuticals

Official Site Inspections

http://www.xerispharma.com Semrush global rank: 2.64 M Semrush visits lastest month: 6.49 K

  • Host name: a23-48-203-144.deploy.static.akamaitechnologies.com
  • IP address: 23.48.203.144
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Xeris Pharmaceuticals" on Search Engine